Download PDF
Thromb Haemost 1996; 75(06): 979-980
DOI: 10.1055/s-0038-1650409
Original Article
Schattauer GmbH Stuttgart

Interleukin-1 in Haemophilic Arthritis

Giuseppe Tagariello
1   Section of Molecular Genetics, University of Sheffield, UK
2   Centro Emofilia, Ospedale Civile, Castelfranco Veneto, Italy
,
Francesco S di Giovine
3   Section of Molecular Medicine, University of Sheffield, UK
› Author Affiliations
Further Information

Publication History

Received: 20 December 1995

Accepted after revision20 February 1996

Publication Date:
27 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Storti E, Traldi A, Tosatti E, Davoli PG. Synovectomy for haemophilic haemarthrosis. Lancet 1968; 292 (02) 572
    PubMedGoogle Scholar
  • 2 di Giovine FS, Duff GW. Interleukin-1: the first Interleukin. Immunology Today 1990; 11: 13-20
    CrossrefPubMedGoogle Scholar
  • 3 Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988; 332 (02) 706-709
    CrossrefPubMedGoogle Scholar
  • 4 Rooney M, Symons JA, Duff GW. Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 1990; 10: 217-219
    CrossrefPubMedGoogle Scholar
  • 5 Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 Receptor Antagonist in Inflammatory Bowel Disease. J Immunol 1995; 154: 2434-2440
    PubMedGoogle Scholar
  • 6 di Giovine FS, Malawista SE, Nuki G, Duff GW. Interleukin-1 as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL-1. J Immunol 1987; 138: 3213-3218
    PubMedGoogle Scholar